Switzerland· 68833001
Glassia 20 mg/ml, Infusionslösung
A alfa1 antitrypsin product, registered in Switzerland by IDEOGEN AG and dispensed under Swissmedic category B. The same ATC class is registered in 11 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Alfa1 antitrypsin is registered in 11 of 19 countries.
Countries holding a registration under ATC B02AB02 (alfa1 antitrypsin), each read from that country’s own register.
- This record: Switzerland
- 7 of them publish a price we can compare per daily dose
Alfa1 antitrypsin · ATC B02AB02
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of alfa1 antitrypsin costs, country by country.
Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.
- Switzerland: $261.83 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Alfa1 antitrypsin · price per daily dose (0.6 g)
USD · FX 28 Sept 2026
- CH Switzerland$261.83
The record
At a glance
- Manufacturer
- IDEOGEN AG
- Country
- Switzerland (CH)
- ATC code
- B02AB02
- ATC class
- Alfa1 antitrypsin
- Defined daily dose
- 0.6 g, P
- Swissmedic category
- B
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B02AB02
Alfa1 antitrypsin, as other registers publish it.
- SwitzerlandGlassia
- CanadaGLASSIATAKEDA CANADA INC
- PolandProlastinGrifols Deutschland GmbH
- SwitzerlandProlastin
- PolandProlastinGrifols Deutschland GmbH
- NetherlandsProlastin 1000 mg, poeder en oplosmiddel voor oplossing voor infusieGrifols Deutschland GmbH
- NetherlandsProlastin 4000 mg, poeder en oplosmiddel voor oplossing voor infusieGrifols Deutschland GmbH
- IrelandProlastin 4000 mg, powder and solvent for solution for infusionGrifols Deutschland GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/96dc0c75-d4b6-4dfc-a42c-512dd5598a4d GET /v1/drugs/96dc0c75-d4b6-4dfc-a42c-512dd5598a4d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Blutprodukte"
}See everything about alfa1 antitrypsin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.